Precision medicine
The company will use the funds to expand operations in the EU and U.S.
HIMSS25
Genetic therapy is effective but can cost millions of dollars. Boro Dropulić, executive director of Caring Cross, says technology innovations and partnerships with hospitals and governments can help lower costs and increase accessibility.
Unlearn leverages digital twin models to simulate how participants may respond to treatments, according to CEO Steve Herne. This approach streamlines clinical trials by enhancing data precision and improving the quality of outcomes.
Amprion CEO Russ Lebovitz says proteins in the brain can misfold and form particles that spread from cell to cell, triggering neurodegenerative diseases. A test can identify these proteins, allowing for early diagnosis before symptoms appear.
The alliance combines ConcertAI's data platform with Bayer's scientific and AI expertise.
The funding round brings the company's total raise to $1.86 billion since it launched in 2018.
The projects will make use of genome sequencing data for more personalized, preventative and cost-effective healthcare.
Researchers claim their invention offers a cost-effective and faster way to do single-cell analysis.
The aim of the partnership is to research how AI can help predict cancer progression.
Also, fitness technology company GOQii has introduced an AI-powered post-organ transplant care programme.